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Abstract
Background: Individuals of African descent in the United States suffer disproportionately from diseases with a metabolic
etiology (obesity, metabolic syndrome, and diabetes), and from the pathological consequences of these disorders
(hypertension and cardiovascular disease).
Methodology/Principal Findings: Using a combination of genetic/genomic and bioinformatics approaches, we identified a
large number of genes that were both differentially expressed between American subjects self-identified to be of either
African or European ancestry and that also contained single nucleotide polymorphisms that distinguish distantly related
ancestral populations. Several of these genes control the metabolism of simple carbohydrates and are direct targets for the
SREBP1, a metabolic transcription factor also differentially expressed between our study populations.
Conclusions/Significance: These data support the concept of stable patterns of gene transcription unique to a geographic
ancestral lineage. Differences in expression of several carbohydrate metabolism genes suggest both genetic and
transcriptional mechanisms contribute to these patterns and may play a role in exacerbating the disproportionate levels of
obesity, diabetes, and cardiovascular disease observed in Americans with African ancestry.
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Introduction
Cardiovascular diseases (CVD) are multifactorial conditions
with strong genetic and environmental influences [1,2]. Despite
many advances in diagnosis and treatment, significant challenges
remain in understanding, treating and possibly preventing these
conditions [3]. Most forms of CVD are multi-factorial, influenced
by genetic predispositions as well as environmental factors. On a
genetic level, the contribution of any single gene is often small,
making investigations of candidate genes difficult to draw any
conclusions towards the etiology of CVD [4,5]. Initial attempts to
characterize the underlying causes of CVD have identified a
plethora of heterogeneous risk factors including: demographic
factors such as family history of premature CVD, gender, and
race; behavioral factors including smoking, diet, and activity level;
metabolic/biochemical factors related to adiposity, plasma
homocysteine, cholesterol levels; and the presence of co-morbid
conditions (for example diabetes and hypertension). Whereas
individual risk factors often lack significance in terms of predictive
power for any given illness, assessment of several risk factors
allows appropriate medical interventions both for prevention and
treatment of CVD [6].
The study of ancestry and genetics is a highly controversial
subject [7,8,9]. However, studies have shown that Americans of
African ancestry have up to a 2.5-fold increased risk of developing
type 2 diabetes, five-fold increased risk of CVD, and eight-fold
increase in mortality from CVD compared to Americans of
European ancestry [10,11]. The molecular basis for the increased
frequency of these disease occurrences in Americans of African
ancestry remains unclear and cannot be adequately explained by
social marginalization or various theories of access to health care
[1,11,12].
The purpose of this study was to identify differential
transcriptional signals associated with CVD susceptibility and
ancestry. Using genetic samples obtained from a cohort of
subjects undergoing cardiac-related evaluation, a strict algorithm
that filtered for genomic features at multiple levels identified
151 differentially-expressed genes between Americans of African
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identified were associated with glucose and simple sugar
metabolism, suggestive of a model whereby selective adaptation
to the nutritional environment differs between populations of
humans separated geographically over time. These observations
represent promising preliminary data indicating that gene
expression profiles can be used to phenotypically describe
ancestral populations. Furthermore, the data offer at least one
potential explanation for the rising incidence of obesity, type 2
diabetes, metabolic syndrome and CVD in the American
population as a whole.
Materials and Methods
Study Guidelines and Processing
Subjects were enrolled in the University of North Carolina
Institutional Review Board approved ‘‘SAMARA’’ study (IRB 04-
MED-471). Exclusion criteria included pregnancy, lymphoma,
leukemia, chronic immunosuppressive therapy, infection with HIV
or HCV, history of solid organ transplant, and anemia. Blood was
drawn early in the day from fasted subjects to minimize signals
associated with nutritional and diurnal cycle and processed within
fifteen minutes. Plasma samples were obtained and RNA and
DNA recovered from leukocytes using a modified one-step acid
guanidinium thiocyanate-phenol-chloroform extraction (RNA-
STAT60, Tel-Test, TX).
Microarray and qRT-PCR Analysis
Labeled cRNA was co-hybridized to Agilent G4112A Whole
Human Genome 44K oligonucleotide arrays with equimolar
amounts of Cyanine-3 labeled Universal Human Reference RNA
(UHRR, Stratagene, LaJolla, CA) as previously described [13].
Complete, MIAME-compliant datasets were deposited with the
Gene Expression Omnibus of the National Center for Biotech-
nology Information and can be accessed through GEO Series
accession number GSE12959. Ten micrograms of total RNA was
reverse transcribed into cDNA using the High Capacity cDNA
Reverse Transcription Kit (ABI, Applied Biosystems, Framing-
ham, MA) and quantitative real-time PCR (qRT-PCR) reactions
were performed using the ABI PRISMH 7900 HT sequence
detection system, software and reagents; see Table S1 for primer
and probe information. RNA input was calibrated with 18S
expression levels and relative mRNA levels were normalized to
levels from the UHRR.
Genotype Analysis
DNA labeling, hybridization, and data extraction were
performed by the DNA Array Core Facility at The Scripps
Research Institute (Jupiter, FL). The Genome-Wide Human SNP
Array 6.0 (AffymetrixH) was used for hybridizations. Identification
of local elements associated with expression (eQTLs) was
performed with linear modeling tools in the software package R.
For a given gene, all SNPs within 10 kb of the untranslated region
were tested. Each SNP was tested by grouping the expression
values based on the genotype and assuming an additive
relationship between number of ‘B’ alleles and expression level.
The genes were selected for differential expression between
ancestries, and PCA illustrated segregation of ethnicities based
on the genotypes. This combination may inflate the theoretical
number of false positives from the linear model. In order to
minimize bias, the eQTL procedure was repeated after random-
izing the gene-SNP pairs. After 100 such randomizations these
permuted statistics were compared to actual statistics in order to
estimate the empirical false discovery rate at each theoretical
p value threshold. This permutation procedure is specific for
identifying local-acting SNPs since it assumes no distant-acting
SNPs, and thus is a conservative estimate in the presence of the
potential selection bias.
Statistical Methods
Microarray data were normalized via the loess local intensity
normalization method of Smyth and Speed [14], and probes were
filtered for features having a normalized intensity of ,30 aFU in
both channels. Probes were removed if ,70% of the data were
present across all samples. Missing data points were imputed using
the k nearest-neighbors algorithm (k=17). 18,375 probes passed
these filters, and were subsequently used for analysis. Scripts
written in the R Statistical Language and Environment (‘‘R’’;
Version 2.2.1, build r36812, release date 2005-12-20.) and Perl
(ActiveState Perl 5.8.1, build 807, release date 2003-11-6) were
used to standardize (m=0,s=1) the data set. Samples were tested
for processing time-dependent correlation with gene expression
and found to be clear of any technical confounding variables [15].
Furthermore, to avoid any potential analysis bias, ancestry was not
associated with subject ID number. Lists of differentially expressed
genes were identified using the statistical analysis of microarray
algorithm [16] (SAM, Version 2.21, release date 2005-8-24;
typical false discovery rate of 1% and 10%), and custom R scripts
written in our laboratory. Unsupervised, semi-supervised, and
supervised clustering analysis were performed on gene lists
essentially as described [17] using Cluster (Version 2.11, http://
rana.lbl.gov/EisenSoftware.htm). Heatmaps of cluster analyses
were visualized with JavaTreeView (Version 1.0.12, release date
2005-3-14; http://sourceforge.net/projects/jtreeview/) [18]. Nearest
centroid classification was performed by calculating two centroids, or
vectors of the class mean (AA or CAU) of each gene. Test cases were
assigned the class of the most similar centroid as measured by
Euclidean distance.
Plasma Fructosamine Assays
Plasma fructosamine levels were determined using the Kamiya
Biosciences (Seattle, WA) Fructosamine Assay Kit, following the
manufacturer’s recommended protocol. Ten microliters of ar-
chived plasma from each subject were utilized for analysis.
Immunoblotting
Plasma protein concentration was determined for each archived
plasma sample (Bio-Rad Quick Start Bradford Assay, Bio-Rad,
Hercules, CA). Twenty-five micrograms of total protein were
reduced, denatured, and resolved on 4–12% NuPAGEH Novex
Bis-Tris Gels (Invitrogen, Carlsbad, CA) in the MES/SDS buffer
system. Proteins were transferred to PVDF membranes, reacted
with chicken anti-human haptoglobin (NB300-330, Novus,
Littleton, CO) and detected with rabbit anti-chicken IGY HRP-
conjugate (Sigma, St. Louis, MO). Bands were visualized with
Pierce ECL Substrate (Pierce, Rockford, IL). Relative levels of
haptoglobin were quantified using Image J (NIH, Bethesda, MD).
Results
Demographics and Covariates Analyses
One hundred and sixty-three subjects referred to cardiology
services at UNC between the ages of 18 and 50 years enrolled in
Phase One of the SAMARA (Supporting a Multi-disciplinary
Approach to Researching Atherosclerosis) study were used for this
analysis. Using unsupervised clustering and principal components
analysis, the variation in gene expression data among the study
subjects resulted in a binary segregation of subjects based on
Genes of Geographic Ancestry
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sian’’ (CAU). Exclusion of gender and coronary artery disease as
confounding factors limited the initial analysis to a ‘‘discovery set’’
of 17 AA and 30 CAU subjects, with equal contributions of gender
per cohort.
Within the discovery set of subjects, four demographic variables
differed significantly in AA versus CAU subjects: lower smoking
pack years and hematocrit levels, and higher occurrence of
hypertension and fructosamine levels (Table 1). These findings are
in line with other studies performed in the United States that
report increased diagnosis of hypertension and decreased mean
hematocrit values and smoking rates in Americans of African
ancestry versus those of European decent [1,11,19].
To test if these demographic variables confounded the analysis
of gene expression within the discovery set, we investigated gene
expression patterns associated with hematocrit levels, smoking
pack-years, hypertension, or fructosamine. A two-class SAM
analysis compared the bottom quartile subjects to top quartile
subjects and negatives to positives for the continuous and
categorical variables, respectively. This method failed to identify
any differentially expressed genes (false discovery rate ,20%).
Alternatively, performing SAM as a quantitative analysis on the
continuous variables yielded the same results, indicating these
clinical and demographic features are unlikely to impair detection
of distinct ancestral transcriptional profiles.
Differences in Glucose Homeostasis
Despite the numerous studies associating increased rates of
metabolic syndrome in persons of African descent, there was no
significant difference in clinical diagnosis of diabetes mellitus or
mean fasting plasma glucose between AA and CAU subjects (data
not shown). We used the measurement of plasma fructosamine as
a surrogate marker for functional diabetes, using a threshold value
of 2.6 mM/L [20]. Fructosamine measures the concentration of
glycated protein adducts in the blood to assess regulation of
glucose levels in the diabetic patient over a time period of weeks.
Consistent with clinical diagnosis and fasting blood glucose data
there was no significant difference between AA and CAU subjects
in the number of subjects with fructosamine levels above
threshold. However, when fructosamine was analyzed as a
continuous variable, we identified significantly higher concentra-
tions in AA compared to CAU subjects (Table 1), suggesting a sub-
clinical predisposition to dysglycemia in AA subjects. Overall, the
observed differences in fructosamine and other variables (Table 1)
within the discovery set of this study agrees with previously
published reports on the same topic, implying that, although the
number of cohorts in each group was relatively small, the two
study groups used in this report are largely representative of their
respective populations in the United States. Importantly, the lack
of correlation between fructosamine levels and gene expression
across our subjects lessens the probability of long-term glucose
homeostasis impairment confounding ancestry-dependent expres-
sion analyses.
Identification of Transcriptional Expression Patterns
Associated with Ancestry
In this discovery set, the SAM statistical technique [16]
identified 2521 probes, corresponding to 2331 genes, that were
significantly differentially expressed between CAU and AA groups,
using a false discovery rate of 1% (Figure 1, Table S2). Given this
large number of differentially expressed genes between the study
groups, we refined these data by concentrating our focus on
Table 1. Demographic variables in the discovery set of
subjects.
Variable p-value AA (n=17) CAU (n=30)
Hypertension{ 0.037 82.40% 46.70%
Fructosamine (mM/L){ 0.033 1.9060.04 1.6860.07
Hematocrit (%){ 0.032 37.5961.20 40.7960.66
Pack Years{ 0.034 8.2662.90 18.7563.83
Categorical{ and continuous{ variables are expressed as percentage of
population group or mean6standard error and differences were considered
significant at p,0.05, calculated by Fisher’s Exact Test, or Student’s T Test,
respectively.
doi:10.1371/journal.pone.0008183.t001
Figure 1. Workflow diagram to identify geo-ancestral genes. The
analysis used to identify geo-ancestral genes involved three primary
steps: 1) Significance of Microarray (SAM) analysis of two distinct
populations in North Carolina, Americans of African or European
ancestry, identified 2531 genes as differentially expressed between the
populations (green); 2) The set of 2531 genes was further restricted to
those genes thanhadSNPs thatdistinguishedto representative ancestral
populations from the HapMap project, a total of 897 genes (yellow);
3)Furtherrestrictiontoonlythosegenesthathaveanabsolutemeanfold
change of 1.3 yielded the set of 151 geo-ancestral genes (purple). SNP
graphic courtesy of David Hall.
doi:10.1371/journal.pone.0008183.g001
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similar populations represented in the HapMap project. The
HapMap project is a collection of genetic differences, i.e. single
nucleotide polymorphisms (SNP), that have been identified
between human populations of different geographical regions
[21]. Using this approach, we identified the differentially expressed
genes from the SAM analysis that contained at least one SNP
(within 10kb of the untranslated regions) that distinguishes two
HapMap populations with similar ancestral origins as our AA and
CAU study groups, the Yoruba people in Ibadan, Nigeria
(abbreviation: YRI) and the CEPH population (Utah residents
with ancestry in northern and western Europe, abbreviation:
CEU), respectively. This analysis uncovered 897 genes (of the
2331 differentially expressed genes in the discovery set, Figure 1)
that had single nucleotide polymorphisms (12,276 total SNPs) that
were statistically different between YRI versus CEPH populations
(p value,1.25E-07, Bonferroni’s corrected p value of 0.01, Table
S2). Further refining the 897 gene list to those genes that had an
absolute mean fold change (MFC) cutoff of greater than 1.3 in our
discovery set resulted in the identification of 151 genes; we define
these genes as ‘‘geo-ancestral genes’’ as they encompass both
geographical and ancestral-based transcriptional characteristics
(Figure 1, Tables 2 and 3).
This approach of filtering the large amount of genetic data
originally pulled from our discovery set yielded results that align
with findings from other groups. Park et al. used a nearest shrunken
centroids methodology to identify SNPs that were unique to each
of the populations studied in the HapMap project, identifying
Table 2. Genes expressed lower in Americans of African versus European ancestry.
D Gene Symbol GBID D Gene Symbol GBID D Gene Symbol GBID
22.79 S100P NM_005980 21.43 SNX27 NM_030918 21.35 TTRAP NM_016614
22.49 SAMD10 NM_080621 21.43 HOXB2 NM_002145 21.34 FLOT1 NM_005803
22.08 PGM1 NM_002633 21.43 PPP2R5A NM_006243 21.34 ABCA7 NM_033308
21.98 MMP9 NM_004994 21.42 GPR97 NM_170776 21.34 HTATIP2 NM_006410
21.96 HP NM_005143 21.42 STX10 NM_003765 21.34 GPR160 NM_014373
21.96 EXOSC6 NM_058219 21.42 TP53I11 BC071606 21.34 DHRS8 NM_016245
21.87 C20orf3 NM_020531 21.42 PKD1-like NM_024874 21.34 FBXL5 NM_033535
21.85 ORM1 NM_000607 21.41 FLJ13052 NM_023018 21.34 DKFZp762O076 NM_018710
21.85 UHSKerB NM_021046 21.41 HIST1H2AI NM_003509 21.33 TXN NM_003329
21.81 CKLFSF1 NM_181294 21.41 IGF2R NM_000876 21.33 RAF1 NM_002880
21.76 COL9A3 NM_001853 21.41 MME NM_007289 21.33 REPS2 NM_004726
21.69 BMX NM_001721 21.40 SNX11 NM_013323 21.33 C20orf24 NM_018840
21.68 QPCT NM_012413 21.39 HEBP2 NM_014320 21.33 LBR NM_194442
21.67 DIRC1 NM_052952 21.39 NS3TP1 NM_019048 21.33 MOSPD2 NM_152581
21.65 GPT NM_005309 21.39 CHI3L1 NM_001276 21.33 SLC40A1 NM_014585
21.64 RAI16 NM_022749 21.39 IFNGR2 NM_005534 21.33 ANPEP NM_001150
21.55 ASGR2 NM_001181 21.39 LOC120224 NM_138788 21.33 PYGL NM_002863
21.54 LCE2A NM_178428 21.38 GCA NM_012198 21.33 GAB2 NM_080491
21.52 ANXA3 NM_005139 21.38 HIST3H2A NM_033445 21.33 DREV1 NM_016025
21.51 KRT23 NM_173213 21.37 ATP6V1B2 NM_001693 21.33 DEGS NM_003676
21.50 USP10 NM_005153 21.37 SEPX1 NM_016332 21.32 SIAT7B NM_006456
21.50 NOV NM_002514 21.37 SIAT10 NM_006100 21.32 ChGn NM_018371
21.50 PPT1 NM_000310 21.37 COPS2 NM_004236 21.32 TPD52L2 NM_199360
21.49 PPP1R12B NM_002481 21.37 OGFRL1 NM_024576 21.32 PLAU NM_002658
21.49 HK2 NM_000189 21.36 ASAH1 NM_004315 21.31 CDA NM_001785
21.49 PGD NM_002631 21.36 PLAUR NM_001005377 21.31 AC093582
21.48 SULF2 NM_198596 21.36 WIPI49 NM_017983 21.31 PAIP2 NM_016480
21.47 MYBPH NM_004997 21.36 F5 NM_000130 21.31 MGC11324 NM_032717
21.47 C7orf19 NM_032831 21.36 ACOX1 NM_007292 21.30 NM_001024688
21.46 LAMP2 NM_013995 21.35 STX3A NM_004177 21.30 MAP4K4 NM_145687
21.46 LMOD1 NM_012134 21.35 RNF135 NM_197939 21.30 CHPT1 NM_020244
21.44 LRWD1 NM_152892 21.35 HIST2H2 NM_003516 21.30 PCTP NM_021213
21.44 CCPG1 NM_020739 21.35 SRPK1 NM_003137 21.30 GALNAC4S-6ST NM_015892
21.44 HIST1H2AD NM_021065 21.35 UBN1 NM_016936
21.44 IFRD1 NM_001550 21.35 GADD45A NM_001924
Data expressed as Log2 mean fold change (D). GenBank identifications (GBID) are provided.
doi:10.1371/journal.pone.0008183.t002
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our data to the results of this study we found that approximately
half of the 897 differentially-expressed ancestral genes, and 71 of
the 151 most strongly differentially expressed genes contained
‘‘ethnically variant SNPs’’ identified by Park, et al.; suggesting that
the delineation of AA and CAU subjects in this study was accurate
(see Table S2). Other studies identified genetically linked gene
expression differences between various HapMap populations
[23,24]. However, comparing the compilation of Stranger et al.
and Spielman et al. to our findings results in only a 9% overlap (see
Table S2); therefore, the integrative approach of filtering gene
expression data from AA and CAU subjects from North Carolina
with existing SNP databases representing African and European
populations both confirm findings from previous studies as well as
identify new patterns of gene expression not previously associated
with ancestry.
Similarities in Allele Frequencies between Discovery Set
and Respective HapMap Populations
Previous studies demonstrate the utility and transferability of
genetic data from the four HapMap populations to distant
ancestral-related populations around the world [25,26,27].
Likewise, we used the assumption that the ancestry of AA and
CAU subjects in this study was similar to the YRI and CEPH
populations, respectively, to generate our list of geo-ancestral
genes. However, to test that this assumption was correct, DNA
from our discovery set was genotyped using the AffymetrixH
Genome-Wide Human SNP Array 6.0, which allowed comparison
of principle component analysis of our data with 90 representative
samples from each of the YRI and CEU populations. Sorting by
the first and second component identified 26 of 30 CAU subjects
as more similar to the CEPH versus YRI population and AA
subjects (Figure 2). Likewise, 16 of 17 AA subjects associated more
with YRI population than the CEPH population and CAU
subjects. The alignment of our CAU and AA study cohorts with
CEPH and YRI populations previously identified by the HapMap
study once again lends credence to accuracy of ethnic identifica-
tion in the present study. Furthermore, it validates the extensive
genetic information in the HapMap database while providing a
suitable resource as an ancestral filter for the data set used in
this study.
Quantitative Verification of the Differential Expression of
Geo-Ancestral Genes
Quantitative real-time polymerase chain reaction (qRT-PCR)
and immunoblot analysis on discovery set samples was used to
Table 3. Genes expressed higher in Americans of African versus European ancestry.
D Gene Symbol GBID D Gene Symbol GBID D Gene Symbol GBID
1.30 CRIP1 NM_001311 1.34 CCL4 NM_002984 1.46 IGJ NM_144646
1.30 FGFR1OP NM_194429 1.34 MTR NM_000254 1.47 TNFRSF17 NM_001192
1.31 NM_016171 1.34 I_3554426 1.50 CD19 NM_001770
1.31 I_3544621 1.35 RPL30 NM_000989 1.50 RPL8 NM_033301
1.32 TM4SF9 NM_005723 1.36 MYLK NM_053025 1.51 SMAD1 NM_005900
1.32 KI0746 NM_015187 1.36 LOC127253 NM_138467 1.52 C21orf81 NM_153750
1.32 RORA NM_134260 1.36 NKG7 NM_005601 1.60 CPNE5 NM_020939
1.32 ZCCHC7 NM_032226 1.36 NM_002304 1.67 AY372690
1.33 FLJ32001 NM_152609 1.36 AL080251 1.67 TCL1A NM_021966
1.33 NG_001019 1.38 NM_001620 1.70 GNG11 NM_004126
1.33 MMD NM_012329 1.38 GZMH NM_033423 1.71 POU2AF1 NM_006235
1.34 POMC NM_000939 1.39 CCL3 NM_002983 1.77 XM_371884
1.34 TAF3 XM_291729 1.41 XM_209178 1.81 IGHG2 BC040042
1.34 LIMS1 NM_004987 1.41 RPS15 NM_001018 1.85 NR_002225
1.34 RPL24 NM_000986 1.41 GNAZ NM_002073 1.91 I_3584237
1.34 SLC12A7 NM_006598 1.44 ZNF234 NM_006630 4.08 PSPHL AJ001612
Data expressed as Log2 mean fold change (D). GenBank identifications (GBID) are provided.
doi:10.1371/journal.pone.0008183.t003
Figure 2. Genomic similarities between North Carolinian and
HapMap populations. Unsupervised principal component analysis
on genotyping data from the AA and CAU discovery set subjects (n=17
and 34, respectively) and samples from each corresponding HapMap
population, YRI and CEU (n=90). Principle component 1 and 2
accounted for 22.7% and 11.6%, respectively, of the variation between
all four populations.
doi:10.1371/journal.pone.0008183.g002
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microarray data reflect true changes in gene expression. In
general, the direction of change in mRNA levels agreed
completely with the microarray analysis, but with larger mean
fold differences (Figure 3A and Table S2). One exception was the
expression of PSPH. Microarray analysis indicated that PSPH and
a similar gene, PSPHL, were expressed higher in AA compared to
CAU subjects. However, the Agilent array probe for PSPH
(A_23_P251984) cannot distinguish between these two transcripts.
Using qRT-PCR probes specific for each transcript thereby
allowed us to determine that PSPHL (but not PSPH) mRNA levels
were differentially expressed between the two groups. Moreover,
qRT-PCR could not detect PSPHL transcript in most CAU
subjects, whereas most AA subjects expressed levels of PSPHL
transcript near the levels of expression seen in the Universal
Human Reference RNA (Figure 3A), indicating near-Boolean
expression patterns of the PSPHL gene between AA and CAU
subjects.
To determine if changes in mRNA can be used to identify
potential quantifiable markers in blood samples from the study
subjects, we measured circulating levels of the plasma protein,
haptoglobin (HP). Haptoglobin is an abundant acute-phase
reactant elevated in a variety of inflammatory conditions and
functions by modulating oxidative damage as well as the salvage of
free hemoglobin via uptake through the macrophage CD163
scavenger receptor [28,29]. Western blot analysis of total plasma
isolated from the subjects used in our study revealed a 2.960.5
fold increase in circulating HP in CAU versus AA subjects
(Figure 3B), consistent with both microarray and qRT-PCR
analysis (Table S2, Figure 3A). Ancestral-based differences in the
levels of plasma haptoglobin are well described in the literature,
and correlate with a multitude of genetic distinctions: allelic
differences in the coding regions of HP [28], SNPs in the upstream
promoter sequences [30], and intronic regulatory elements [31].
Importantly, a number of recent studies implicate the absolute
amount and quality of the HP gene product as an independent risk
factor for a multitude of diseases including: diabetes [32];
atherosclerosis [33]; poor clinical outcome following myocardial
infarction [28,34]; and percutaneous coronary interventions
[34,35]. In all of these cases, lower levels of functional haptoglobin
increase the likelihood of developing diabetes and cardiovascular
disease.
Validation of Ancestral Patterns of Gene Expression
In order to determine how predictive our geo-ancestral gene set
was of the general population, we used an independent validation
set comprised of 112 unrelated subjects, similarly classified by
self-reported ancestry (32 AA and 80 CAU), to validate the 151
Figure 3. Confirmation of differential gene expression. To verify actual changes in gene expression identified in our analysis, a selected
number of genes were measured by Quantitative real-time PCR (qRT-PCR) and/or immunublot analysis. A) Results of qRT-PCR analysis of the
discovery set subjects normalized to the Universal Human RNA Reference (left, heatmap) or as the mean fold change between AA and CAU discovery
set cohorts (right, table) n=17 and 34, respectively. All data represented in Log2. The differences between AA and CAU subjects were considered
significant at p,0.05 for all mRNAs shown, except for PSPH (indicated by *). B) Immunoblot analysis of Haptoglobin (Hp) in plasma protein samples
from randomly selected AA and CAU discovery set subjects (AA samples indicated by {). Immunoreactive bands were observed at the predicted
molecular weight, 46 kDa. C) Densitometry analysis presented as the relative amount of Haptoglobin6SEM (n=6 per group) results in a 2.960.5 fold
increase in Haptoglobin protein in plasma from CAU versus AA subjects.
doi:10.1371/journal.pone.0008183.g003
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the 151 genes (67.5%) as differentially expressed at a p value of
#0.05 (range: p=8.32610
216 (PSPHL) to p=4.96610
22 (STX3A);
Table S2). Furthermore, using the 151 genes for supervised
principle component analysis, AA and CAU subjects successfully
separated both discovery and validation sets. As expected, principal
component analysis successfully grouped the discovery set subjects,
with less than 7.0% misclassification (1/17 AA and 2/30 CAU,
Figure 4A). Parallel analysis on the validation set led to a similar
level of ancestral discrimination in the independent subjects
(Figure 4B). A simple nearest centroid classifier built from all 151
genes yielded 84% accuracy in the validation set. These data
validate the gene expression patterns observedinthediscoverysetof
47 subjects, and demonstrate that these geo-ancestral genes are in
fact stable phenotypes in Americans of African and European
ancestry. Understanding the functional relationships within this
gene set could potentially help in explaining the disproportionate
predisposition of CVD and other diseases between these popula-
tions, a topic that we explore below.
Ancestral Differences in Expression of Carbohydrate
Metabolic Genes
Numerous genes expressed at lower levels in AA relative to CAU
participate in glucose metabolism (Table 2): primary carbohydrate
metabolism (HK2, PYGL, GPT, and PGM1); pentose phosphate
shunt (PGD); and glycosylation of proteins and lipids (ST3GAL6,
SULF2, GALNAC4S-6ST, and ChGn). Interestingly, the decreased
expression of these genes in the AA cohort was notable because of
the increased plasma fructosamine levels in these same subjects
(Table 1). These results suggest that differences in glucose
metabolism between Americans of African and European may
reside at the transcriptional level. The down-regulation of these genes
in the AA cohorts argues against these changes being a
compensatory response to hyperglycemia and suggests instead a
genetic adaptation to changes in the availability of dietary sugars
that may no longer be appropriate to a Western Diet. In order to
explore this ideafurtherandtodeterminethefunctionalimportance
of the genetic differences we identified, we used hyperclustering
analysis of our geo-ancestral gene set to test for differential
expression of gene sets that underlie common biological process.
Hyperclustering is a method of associating genes with significant
enrichments in Gene Ontologies, KEGG pathways, and TRANS-
FACanalysis [13]. Using thismethodologyon the 151 geo-ancestral
genes, we were able to identify three functional hyperclusters:
Carbohydrate Metabolism, Amino Acid Biosynthesis, and Chemo-
taxis (Figure 5). Of the eight GO categories and four KEGG
pathways enriched at a threshold of p#0.01, half belonged to the
Carbohydrate Metabolism hypercluster. These overrepresented
KEGG pathways and Gene Ontologies within the Carbohydrate
Metabolism hypercluster reaffirm the initial observation of
differential expression of carbohydrate metabolic genes, and begin
to shed light on factors that may affect glycemic regulation in
different ancestral populations.
Regulation of Geo-Ancestral Genes by the Transcription
Factor SREBP1
We next extended our analysis to include algorithms for
identifying transcription factor binding sites in the promoter region
of differentially expressed genes. This analysis led to the
identification of significantly enriched binding sites (p#0.02) of
four predicted transcription factors in the gene set: AML6,
HNF3a, E2F1, and SREBP1. Although transcription factor
activity can be influenced by several factors, such as post-
transcriptional and post-translational modifications and the
availability of co-activators and co-repressors, the direction of
change in overall activity predicts a complementary change in
expression of target genes. The only significant enrichment in
either up- or down-regulated target genes of the four transcription
factors was SREBP1, exhibiting a 2.9-fold enrichment in down-
regulated genes (p,0.05, Table S3). Consistent with this
observation, microarray and qRT-PCR analysis identified expres-
sion for the gene encoding for SREBP1, SREBF1, as significantly
decreased by 0.360.1-fold in AA relative to CAU subjects (t-test
p,0.001, SAM q-value of zero, qRT-PCR p,0.05, Figure 3A,
Table S2).
Although SREBP1 was initially characterized as a primary
regulator of cholesterol anabolic genes [36], recent studies in animal
models detail the critical role SREBP1 plays in the long-term
control of both lipid and glucose homeostasis in an insulin-dependent
manner. As such, SREBP1 mediates the regulation of insulin and
glucose responsive genes in a variety of tissues, including skeletal
muscle, liver, adipose, and the pancreatic islets of Langerhans
[37,38,39]. Promoters of five of the eight genes in the carbohydrate
Figure 4. Validation of geo-ancestral genes. The 151 geo-
ancestral genes were used to perform supervised principle components
analysis of the discovery set of 47 subjects (A) and the validation set of
112 unrelated subjects (B). The first and second principle components
effectively segregated the AA and CAU populations in both cases.
doi:10.1371/journal.pone.0008183.g004
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motifs. Importantly, while a sequence algorithm identified potential
SREBP1 binding sites in these genes, ChIP analysis and DNase
footprinting determined SREBP1 directly interacts with the promoters
and mediates the transcription of both HKII [40] and PGD [41],
which encode the first enzymes in glycolysis and the pentose
Figure 5. Hyperclustering geo-ancestral genes identify three functional groups. Using the 151 geo-ancestral genes, GATHER identified
significantly enriched categories of Gene Ontologies, KEGG pathways and TRANSFAC predicted binding sites. A) Hyperclustering of geo-ancestral
genes: relative gene expression values are represented by the yellow-blue scale (Log2 mean fold change); Inclusion in a functional class of either Gene
Ontologies (GO) or KEGG pathways is initiated by green; and predicted TRANSFAC binding sites (TF) are represented as the mean fold change
between AA and CAU (using the yellow-blue scale). This resulted in three functional hyperclusters (HC): 1) ‘‘Carbohydrate Metabolism’’; 2) ‘‘Amino Acid
Biosynthesis’’; and 3) ‘‘Chemotaxis’’. B) Detail showing the average relative gene expression (AA vs CAU) and functional categories for each
hypercluster.
doi:10.1371/journal.pone.0008183.g005
Genes of Geographic Ancestry
PLoS ONE | www.plosone.org 8 December 2009 | Volume 4 | Issue 12 | e8183phosphate pathway, respectively. These data provide a mechanism
by which a decrease in SREBP1 expression and transcriptional
activity promotes the differential expression of several geo-ancestral
genes including multiple carbohydrate metabolic genes.
The Influence of cis-Acting Elements Associated with
Gene Expression
Gene expression is influenced by a variety of factors, such as the
thousands of common cis-acting variations that occur in the
population as well as trans-acting factors, such as the activity of
transcription factors, RNA processing, and signaling molecules
[42]. Expression quantitative trait locus (eQTL) analysis combines
gene expression and genotyping (i.e. SNP) data to determine if
changes in gene expression correlate to variations in genomic
sequence. We used local eQTL analysis to identify cis-acting
genetic contributions to the differential expression pattern of the
geo-ancestral genes.
Differentially expressed genes and SNP associations were both
identified with respect to ancestry; as such, the association between
genotype and gene expression may be artificially increased (Figure
S1). This potential bias was minimized by permutation of the SNP
– gene pairs. Association of a SNP with expression after this
permutation is assumed to be due to the selection bias. This
procedure generates a distribution from which to calculate the
expected false discovery rate for a threshold and corresponding set
of candidate eQTLs. Comparing the number of observed p values
versus expected p values from permutation resulted in more eQTL
associations than expected at reasonable thresholds (e.g. 16
observed eQTLs compared to 3 expected SNP; FDR=15.8%,
p,0.00025, Table S4). Overall, 119 of the 151 genes were
represented by a total of 3241 SNPs, with 106 and 312 SNPs
associating with expression or race, respectively (additive or
Cochran-Armitage model, p,0.01, Figure 6, and Table S2).
Local eQTL analysis also allowed us to determine the potential
influence of cis-acting elements on the differential expression of the
previously discussed cadre of carbohydrate metabolic genes. From
the eight metabolic genes represented in the Carbohydrate
Metabolism hypercluster, four had local eQTL (CHGN, PGM1,
HK2, and PYGL), and all but PGD contained SNPs that associated
with race. However, out of this metabolic cluster only PYGL had a
proportion of eQTL (number of eQTL per total number of gene
SNPs, 3.8%, additive model p,0.01) greater than the mean
proportion of eQTL from the entire geo-ancestral gene list (3.3%).
A similar trend was seen using the proportion of ancestry-
associated SNPs (Cochran-Armitage model, Table S2) suggesting
that relative to the geo-ancestral list, other factors not defined by
these eQTLs may contribute to the differential expression of
metabolic genes. In combination with the presence of SREBP1
binding sites in these carbohydrate metabolic genes and the
observed decreased in SREBF1 expression in AA versus CAU
subjects, these data suggest that both trans-acting elements, such as
SREBP1 activity, and hereditary cis-acting elements contribute to
the differential expression of the carbohydrate metabolic genes
identified in this study (Figure 7).
Discussion
Characterizing inherited patterns of gene transcription is crucial
in understanding the meaning of signals related to disease states
that vary in incidence across different ancestral populations. This
knowledge not only informs the disease data analysis process, it
provides important insight into the range of baseline transcrip-
tional regulation in human populations. The International
HapMap Project characterizes the scope of genetic differences
by genomic sequencing human populations from different
geographical areas: Europe, Asia, and Africa. It is important to
emphasize that the HapMap Project is highly informative, despite
small numbers of subjects from different ancestries: for example,
the YRI and CEU datasets derive from 90 total subjects each (30
trios of two parents and an adult child). This effort tabulated
millions of single nucleotide polymorphisms within these popula-
tions [21]. Several groups have used these data to explore the
genetic components of multi-factorial diseases [43,44]. Recently,
whole genome scans identified single nucleotide polymorphisms
(SNPs) within the p21.3 region of chromosome 9 that are
associated with increased risk of cardiovascular disease and
myocardial infarction in Caucasian populations [45,46,47].
Although there is no mechanistic data on the association of these
non-coding SNPs with disease, it is likely that these silent
polymorphisms are associated with transcriptional control of gene
expression [48]. The burgeoning correlations between whole-
genome SNP patterns and transcriptional regulation is redefining
the use of integrative genomics to understand multi-factorial
diseases, such as cardiovascular and metabolic diseases [49].
We acknowledge that multi-center genome-wide association
studies on cardiovascular disease and diabetes include very large
cohorts; however, our approach was designed to better understand
disease biology by identifying heritable traits that influence gene
expression, not to identify genetic markers solely based on their
predictive power of a disease state. Using this approach, the largest
transcriptional difference observed in this study was associated with
the self-reported ancestry of the subjects. It can be argued that the
concept of race, especially self-reported race can be unreliable.
However, the correlation between genetic data obtained from our
Figure 6. Increase in associations between SNPs and expres-
sion of the geo-ancestral genes. The p value of the observed versus
predicted eQTLs are plotted using the additive model of association.
Data points above the line x=y (-- ) indicate p values that are smaller
than expected due to chance after correcting for selection bias. There
were 3241 SNPs found in the 151 geo-ancestral genes, 106 of which
associated with expression at a p,0.01 (red) with the remainder at
p$0.01 (blue).
doi:10.1371/journal.pone.0008183.g006
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from other groups studying similar ancestral populations supports
the validity of our cohort partitioning. Indeed, an integrative data
analysis, incorporating SNPs identified in the HapMap project,
identified differentially expressed genes between Americans of
African (AA) and European (CAU) ancestry in the United States
that were also structurally distinct between European and African
populations (as identified in the HapMap project) that we classified
as ‘‘geo-ancestral genes’’. Many of the geo-ancestral genes expressed at
lower levels in AA compared to CAU subjects were associated with
carbohydrate and glucose metabolism. This subset of genes
contained local eQTLs (cis-acting) as well as predicted and/or
confirmed binding sites for the metabolic transcription factor,
SREBP1 (trans-acting), also expressed lower in AA subjects
(Figure 7). These results are consistent with the observations that
Americans of African ancestry are disproportionately affected by
obesity, metabolic syndrome, type 2 diabetes, and cardiovascular
disease [1] as well as recent studies classifying SREBF1 as a
candidate gene both at an expression and genetic level for these
samediseases [50,51,52,53,54].Studies suggest that variations at cis-
regulatory polymorphisms account for more of the population
differences in prevalence of complex diseases versus trans effects
[23,24,42]. Likewise, future studies including analysis of SREBF1
polymorphisms within our study populations and distant eQTL
studies to identify other loci that contribute to the regulation of
carbohydrate metabolic gene expression should be considered.
A study of the nutritional patterns and diabetes risk among
American children demonstrated that, despite better overall compli-
ance with the FDA recommended ‘‘Food Pyramid,’’ American
children of African ancestry remained at higher risk for the
development of diabetes and pre-diabetic conditions [55]. One
interpretation of our findings is that differences in metabolic
expression profiles between AA and CAU subjects may not be the
sole result of differing nutritional and dietary practices between the
study groups. Likewise, diabetics studied within the Seventh Day
Adventist Church revealed less benefit for American patients of
African versus European ancestry when both groups adhered to the
religious dietary practices of the denomination [56]. More focused
studies are needed to determine and identify the contribution of
genetics to dietary responses, in particular subjects at high risk for
multi-factorial diseases such as cardiovascular disease and diabetes.
Our study identifies ancestral-dependent patterns of gene expression
that may contribute to the differential adaptations of dietary changes
and if better understood, could help therapeutically.
Supporting Information
Figure S1 Illustrating the p-value distributions from different
association tests. An eQTL analysis was performed using an additive
(left) or genotype (middle) model. In both cases, there is enrichment
of small p-values beyond what is expected due to chance. This
enrichment is likely due to selection bias because both SNPs and
geneswereselected basedontheirassociation withselfreportedrace.
Found at: doi:10.1371/journal.pone.0008183.s001 (0.87 MB TIF)
Table S1 Real-time qPCR reagents. Quadruplicate reactions
from each subject’s RNA sample were performed (N=47 subjects;
Figure 7. Contributions of cis- and trans-acting variations to disease pathogenesis. The level of gene expression is influenced by both cis-
and trans-acting factors. Analysis of the carbohydrate metabolic hypercluster identified in the geo-ancestral genes identified both SNPs (cis, top) and
transcription factors such as SREBP1 (trans, bottom) that function on a genomic level (green) contributing to the expression of genes (blue) such as
PYGL and HKII. The enzymes encoded by these genes contribute in carbohydrate and glucose metabolism (yellow) and likely contribute to the
increase the predisposition to multi-factorial diseases (red) in Americans of African versus European ancestry.
doi:10.1371/journal.pone.0008183.g007
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RNA input was calibrated with 18S expression levels and relative
mRNA levels were normalized to levels from the UHRR
(Stratagene, LaJolla, CA). *Determined using ProbeFinder
(version 2.44) and the Universal ProbeLibrary (Roche Applied
Science, Indianapolis, IN).
Found at: doi:10.1371/journal.pone.0008183.s002 (1.39 MB
XLS)
Table S2 SNP, gene expression, qRT-PCR, and eQTL analysis.
Found at: doi:10.1371/journal.pone.0008183.s003 (1.48 MB
XLS)
Table S3 TRANSFAC enrichment analysis. For each predicted
TRANSFAC binding site the actual and predicted number (shown
in parentheses) are provided assuming an equal distribution
between up- and down-regulated genes. * indicates distributions
considered unequal at p,0.05, d=fold-enrichment in down-
regulated genes.
Found at: doi:10.1371/journal.pone.0008183.s004 (1.39 MB
XLS)
Table S4 eQTL false discovery rates (FDR) in geo-ancestral
genes.
Found at: doi:10.1371/journal.pone.0008183.s005 (1.39 MB
XLS)
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